{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:16:44Z","timestamp":1789715804503,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.clim.2008.05.006","type":"journal-article","created":{"date-parts":[[2008,7,3]],"date-time":"2008-07-03T11:48:41Z","timestamp":1215085721000},"page":"374-381","source":"Crossref","is-referenced-by-count":24,"title":["Identification of CTLA-4 isoforms produced by alternative splicing and their association with myasthenia gravis"],"prefix":"10.1016","volume":"128","author":[{"given":"Ming","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kakoulidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Giscombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritva","family":"Pirskanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Kari","family":"Lefvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Klareskog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiongBiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2008.05.006_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000065639","article-title":"Epidemiology of myasthenia gravis: a population-based study in Stockholm, Sweden","volume":"21","author":"Kalb","year":"2002","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.clim.2008.05.006_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0960-5428(94)00040-U","article-title":"The role of the thymus in myasthenia gravis","volume":"4","author":"Hohlfeld","year":"1994","journal-title":"Adv. Neuroimmunol."},{"key":"10.1016\/j.clim.2008.05.006_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev.immunol.24.021605.090535","article-title":"A molecular perspective of CTLA-4 function","volume":"24","author":"Teft","year":"2006","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2008.05.006_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/sj.gene.6363816","article-title":"CDS1 and promoter single nucleotide polymorphisms of the CTLA-4 gene in human myasthenia gravis","volume":"3","author":"Wang","year":"2002","journal-title":"Genes Immun."},{"key":"10.1016\/j.clim.2008.05.006_bib5","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0165-5728(02)00228-X","article-title":"Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence","volume":"130","author":"Wang","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2008.05.006_bib6","doi-asserted-by":"crossref","first-page":"6430","DOI":"10.4049\/jimmunol.166.10.6430","article-title":"Anti-CTLA-4 antibody treatment triggers determinant spreading and enhances murine myasthenia gravis","volume":"166","author":"Wang","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2008.05.006_bib7","doi-asserted-by":"crossref","first-page":"6676","DOI":"10.1073\/pnas.1131898100","article-title":"A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4+ T cells","volume":"100","author":"Paas-Rozner","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2008.05.006_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.0300-9475.2001.01019.x","article-title":"Expression of CTLA-4 by human monocytes","volume":"55","author":"Wang","year":"2002","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2008.05.006_bib9","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.4049\/jimmunol.166.11.6893","article-title":"Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4","volume":"166","author":"Im","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2008.05.006_bib10","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.4049\/jimmunol.164.10.5015","article-title":"Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease","volume":"164","author":"Oaks","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2008.05.006_bib11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/cimm.2000.1649","article-title":"A native soluble form of CTLA-4","volume":"201","author":"Oaks","year":"2000","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.clim.2008.05.006_bib12","first-page":"336","article-title":"The soluble CTLA-4 receptor: a new marker in autoimmune diseases","volume":"53","author":"Pawlak","year":"2005","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"10.1016\/j.clim.2008.05.006_bib13","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature01621","article-title":"Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease","volume":"423","author":"Ueda","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.clim.2008.05.006_bib14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S1074-7613(04)00110-4","article-title":"An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells","volume":"20","author":"Vijayakrishnan","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2008.05.006_bib15","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.4049\/jimmunol.157.11.4762","article-title":"Regulation of surface and intracellular expression of CTLA4 on mouse T cells","volume":"157","author":"Alegre","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2008.05.006_bib16","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.4049\/jimmunol.171.7.3459","article-title":"Diversity of clonal T cell proliferation is mediated by differential expression of CD152 (CTLA-4) on the cell surface of activated individual T lymphocytes","volume":"171","author":"Maszyna","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2008.05.006_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4049\/jimmunol.175.1.177","article-title":"B7-independent inhibition of T cells by CTLA-4","volume":"175","author":"Chikuma","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2008.05.006_bib18","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/eji.200526168","article-title":"Association of CTLA4 polymorphism with regulatory T cell frequency","volume":"35","author":"Atabani","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2008.05.006_bib19","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.molimm.2006.08.010","article-title":"Genetic variation in ICOS regulates mRNA levels of ICOS and splicing isoforms of CTLA4","volume":"44","author":"Kaartinen","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.clim.2008.05.006_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1740-2557-2-8","article-title":"Lack of correlation between the levels of soluble cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and the CT-60 genotypes","volume":"2","author":"Purohit","year":"2005","journal-title":"J. Autoimmun. Dis."},{"key":"10.1016\/j.clim.2008.05.006_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2350-8-3","article-title":"CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in Northern Sweden","volume":"8","author":"Mayans","year":"2007","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.clim.2008.05.006_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/clim.1999.4743","article-title":"Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells","volume":"92","author":"Nagaraju","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2008.05.006_bib23","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/00007890-200204270-00019","article-title":"Detection of a novel specificity (CTLA-4) in ATG\/TMG globulins and sera from ATG-treated leukemic patients","volume":"73","author":"Pistillo","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.clim.2008.05.006_bib24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.clim.2007.01.003","article-title":"Soluble CTLA-4 in autoimmune thyroid diseases: relationship with clinical status and possible role in the immune response dysregulation","volume":"123","author":"Saverino","year":"2007","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2008.05.006_bib25","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3596::AID-IMMU3596>3.0.CO;2-Y","article-title":"A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells","volume":"29","author":"Magistrelli","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2008.05.006_bib26","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1101\/gad.1048803","article-title":"Pre-mRNA splicing and human disease","volume":"17","author":"Faustino","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.clim.2008.05.006_bib27","doi-asserted-by":"crossref","first-page":"9327","DOI":"10.1128\/MCB.23.24.9327-9337.2003","article-title":"A stem structure in fibroblast growth factor receptor 2 transcripts mediates cell-type-specific splicing by approximating intronic control elements","volume":"23","author":"Baraniak","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.clim.2008.05.006_bib28","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s00018-004-4001-7","article-title":"Alternative splicing of Bcl-2-related genes: functional consequences and potential therapeutic applications","volume":"61","author":"Akgul","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.clim.2008.05.006_bib29","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0092-8674(87)90617-9","article-title":"Developmentally induced, muscle-specific trans factors control the differential splicing of alternative and constitutive troponin T exons","volume":"49","author":"Breitbart","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.clim.2008.05.006_bib30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0168-9525(97)01324-3","article-title":"Neurexins: three genes and 1001 products","volume":"14","author":"Missler","year":"1998","journal-title":"Trends Genet."},{"key":"10.1016\/j.clim.2008.05.006_bib31","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1182\/blood.V92.11.4404","article-title":"Characterization of multiple isoforms of protein 4.1R expressed during erythroid terminal differentiation","volume":"92","author":"Gascard","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.clim.2008.05.006_bib32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0163-7258(99)00067-4","article-title":"Modification of alternative splicing pathways as a potential approach to chemotherapy","volume":"85","author":"Mercatante","year":"2000","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.clim.2008.05.006_bib33","doi-asserted-by":"crossref","first-page":"49374","DOI":"10.1074\/jbc.M209236200","article-title":"Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents","volume":"277","author":"Mercatante","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2008.05.006_bib34","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/0168-9525(96)10037-8","article-title":"Directing alternative splicing: cast and scenarios","volume":"12","author":"Chabot","year":"1996","journal-title":"Trends Genet."},{"key":"10.1016\/j.clim.2008.05.006_bib35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev.bi.56.070187.002343","article-title":"Alternative splicing: a ubiquitous mechanism for the generation of multiple protein isoforms from single genes","volume":"56","author":"Breitbart","year":"1987","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.clim.2008.05.006_bib36","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1146\/annurev.ge.23.120189.002523","article-title":"Alternative splicing in the control of gene expression","volume":"23","author":"Smith","year":"1989","journal-title":"Annu. Rev. Genet."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661608006748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661608006748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T02:27:47Z","timestamp":1684463267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661608006748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S1521661608006748"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2008.05.006","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}